Results 131 to 140 of about 2,289 (152)
Some of the next articles are maybe not open access.
Clinicopathologic presentations of dermatomycoses in cancer patients
Journal of the European Academy of Dermatology and Venereology, 2008AbstractMany of the skin fungal infections in cancer patients may look similar to those infections in non‐cancer patients. However, in some cases, they become more extensive and even life threatening. Prolonged and severe neutropenia is the main risk factor for the dramatic issue of fungal infections.
Pascale Quatresooz +3 more
openaire +2 more sources
A preliminary survey of dermatomycoses in Bangalore
Proceedings / Indian Academy of Sciences, 1971Clinical and mycological investigations were made on 225 cases of suspected dermatomycoses. Of these, 102 were microscopically positive. But only 63 were culturally positive, and these are analysed here with regard to clinical patterns and aetiological species, age, sex and occupational incidence and susceptibility to griseofulvinin vitro.
Indira, PU, Sirsi, M, Krishnamurthi, N
openaire +2 more sources
Der Hautarzt, 2009
The clinical relevance of mycotic infections of the skin and mucous membranes is often underestimated, although their number and duration are far greater than for all other microbial infections, and a rising incidence can be observed in childhood. An overview of important mycotic infections and their dermatologic manifestations is given here, with ...
Daniela Bruch-Gerharz, Ruzicka T
openaire +3 more sources
The clinical relevance of mycotic infections of the skin and mucous membranes is often underestimated, although their number and duration are far greater than for all other microbial infections, and a rising incidence can be observed in childhood. An overview of important mycotic infections and their dermatologic manifestations is given here, with ...
Daniela Bruch-Gerharz, Ruzicka T
openaire +3 more sources
Common Environmental Dermatomycoses
2018Environmental fungal skin disorders (EFSD) or dermatomycoses have a worldwide distribution, with high prevalence in most developing countries. Causal agents include dermatophytes and opportunistic fungi (Malassezia, Candida, Trichosporon, Rhodotorula, Cryptococcus or Aspergillus, Geotrichum, Alternaria, etc.).
openaire +2 more sources
Treatment of Tropical Dermatomycoses with Haloprogin
Mycoses, 2009Summary: A clinical trial with Mycanden (active substance haloprogin) in the treatment of a variety of tropical dermatomycoses in 54 indigenous patients showed that the drug was an effective topical antimycotic against candidiasis and a number of dermatophyte infections - especially Tinea cruris and Tinea pedis, in which nearly 100% healing was ...
Harish C. Gugnani +2 more
openaire +3 more sources
Treatment of Dermatomycoses with Topical Tioconazole and Miconazole
Dermatology, 1983A total of 60 patients with proven fungal infection of the skin took part in a single-blind comparative study of the efficacy, toleration and safety of tioconazole base 1 % w/w and miconazole nitrate 2% creams applied twice daily for 14 days to patients with pityriasis versicolor and for 28 days to patients with dermatophyte and yeast infections ...
openaire +3 more sources
Dermatomycoses: Challenges and Human Immune Responses
Current Protein & Peptide Science, 2014The most prevalent skin infections are mainly caused by species of dermatophytes of the genera Trichophyton, Microsporum, and Epidermophyton that infect keratinized tissues and stratum corneum of skin and hair. Besides proteases with putative role of kinases and other enzymes, immune modulators are abundantly secreted during infection as well.
Muzna Zahur +3 more
openaire +3 more sources
Treatment of dermatomycoses and onychomycoses-state of the art
Clinical and Experimental Dermatology, 1992We have reached a stage whereby many of the superficial mycoses are treatable with short courses of antifungal drugs. However, the minimum duration of therapy has still not been well defined and there remain some mycoses which do not respond to conventional therapy.
openaire +2 more sources
Commentary: Treatment of Dermatomycoses With Griseofulvin
Archives of Dermatology, 1982There is an implied serious responsibility to anyone who introduces a new drug into medicine, especially if its effects will be systemic and it is taken by patients for months or years. Therefore, it was a source of personal satisfaction for me to review Index Medicus back to 1959 and find no clear-cut case of a patient who died of griseofulvin ...
openaire +2 more sources
Mycoses, 2002